BioCryst Pharmaceuticals Inc

25 Sept 2026, 19:25 UTC

BioCryst Pharmaceuticals Inc shares are experiencing a modest increase, having reached a peak earlier in the session before settling slightly higher.

24 Sept 2026, 23:25 UTC

BioCryst Pharmaceuticals Inc declined in after-market trading, remaining near the lower end of its one-month range and significantly below its 20-day moving average.

23 Sept 2026, 19:21 UTC

BioCryst Pharmaceuticals Inc shares fell as the broader market declines, remaining significantly below the 20-day moving average and near the lower end of its one-month range.

21 Sept 2026, 19:35 UTC

BioCryst Pharmaceuticals Inc is trading higher, having reached a peak return earlier in the session, though it remains below its 20-day moving average.

18 Sept 2026, 22:25 UTC

BioCryst Pharmaceuticals Inc's stock is trading modestly lower in after-market hours, retracing significantly since Friday's close and positioned near its one-month trading range low.

17 Sept 2026, 20:07 UTC

BioCryst Pharmaceuticals Inc is advancing during Thursday's session, continuing a positive trend since Wednesday, despite remaining below its 20-day moving average.

16 Sept 2026, 22:21 UTC

BioCryst Pharmaceuticals Inc's shares declined modestly in after-market trading, remaining significantly below the 20-day moving average and near the lower end of its one-month range.

15 Sept 2026, 20:21 UTC

BioCryst Pharmaceuticals shares are higher in after-market trading, gaining ground despite broader market caution and no specific company news identified.

14 Sept 2026, 23:06 UTC

BioCryst Pharmaceuticals Inc shares are higher in after-market hours, recovering from an earlier decline. No specific news was identified to explain the movement.

11 Sept 2026, 20:08 UTC

BioCryst Pharmaceuticals Inc is lower today, continuing a seven-session decline amid macroeconomic data showing inflation rates in line with expectations.

10 Sept 2026, 23:26 UTC

No specific news was identified for BioCryst Pharmaceuticals Inc. in after-market trading. Shares remained effectively flat since Thursday's close.

9 Sept 2026, 23:46 UTC

BioCryst Pharmaceuticals Inc. shares are higher in after-market trading, despite a generally flat performance and remaining below their 20-day moving average.

8 Sept 2026, 23:16 UTC

BioCryst Pharmaceuticals shares are higher in after-market hours, despite four consecutive lower closes. No specific news was identified to explain the price movement.

3 Sept 2026, 20:07 UTC

BioCryst Pharmaceuticals Inc shares are lower today, continuing a decline since Wednesday. No specific news has been identified to explain the movement.

2 Sept 2026, 23:46 UTC

BioCryst Pharmaceuticals Inc shares are lower in after-market hours. No specific news was identified to explain the decline amid broader market sentiment shifts.

1 Sept 2026, 22:26 UTC

BioCryst Pharmaceuticals Inc shares are higher in after-market hours following a stable performance. No specific news was identified to explain the price movement.

31 Aug 2026, 20:07 UTC

BioCryst Pharmaceuticals Inc shares are lower today amid broader market declines following inflation concerns from the Jackson Hole Economic Symposium.

28 Aug 2026, 19:16 UTC

BioCryst Pharmaceuticals shares are lower despite reporting Q2 2026 revenue of $218.3 million, reflecting broader market trends and valuation discounts.

27 Aug 2026, 20:07 UTC

BioCryst Pharmaceuticals shares are higher as positive jobless claims data boosts market sentiment. The stock stabilized after reaching a session high.

26 Aug 2026, 19:36 UTC

BioCryst Pharmaceuticals received marketing approval for ORLADEYO in pediatric patients. Shares are lower today amid broader market trends and inflation data.

24 Aug 2026, 19:26 UTC

BioCryst Pharmaceuticals Inc shares are trading higher, maintaining a position above the 20-day moving average and near the midpoint of their one-month range.

21 Aug 2026, 22:26 UTC

BioCryst Pharmaceuticals shares moved higher in after-hours trading, reaching a session high before slightly retracing. No specific news was identified to explain the movement.

20 Aug 2026, 20:01 UTC

BioCryst Pharmaceuticals Inc shares are lower amid a decline in the Biotechnology sub-sector. Earlier in the session, shares rebounded from a session high.

19 Aug 2026, 23:01 UTC

BioCryst Pharmaceuticals Inc shares are lower in after-market trading, retracing from an earlier uptick with no specific news identified to explain the decline.

18 Aug 2026, 20:06 UTC

BioCryst Pharmaceuticals Inc shares are declining amid broader market weakness, with no specific news identified to explain today's price movement.

14 Aug 2026, 19:06 UTC

BioCryst Pharmaceuticals is lower today, following broader market concerns over an unexpected drop in U.S. retail sales impacting Federal Reserve interest rate policy.

13 Aug 2026, 21:31 UTC

BioCryst Pharmaceuticals shares traded roughly flat in after-market hours, remaining within their one-month range and above the 20-day moving average.

12 Aug 2026, 19:41 UTC

BioCryst Pharmaceuticals shares are higher today, rebounding from an earlier dip and reflecting notable volatility during the session. The stock remains above its 20-day moving average.

11 Aug 2026, 23:26 UTC

BioCryst Pharmaceuticals Inc shares are lower in after-market hours, reflecting a decline since Tuesday's close amid broader market weakness and cautious sentiment.

10 Aug 2026, 19:51 UTC

BioCryst Pharmaceuticals Inc. shares are higher after Wall Street Zen upgraded its rating to "strong-buy." Other firms also adjusted price targets amid market uncertainty.